Highlights
NASDAQ: KIN       Kindred Biosciences
Last Price Today's Change   Day's Range   Trading Volume
9.29   -0.01 (0.11%)  9.29 - 9.56  17,176

Overview

 
Avg Volume (4 weeks):200,283
4 Weeks Range:8.23 - 10.68
4 Weeks Price Volatility (%):
43.27%
52 Weeks Range:5.96 - 11.35
52 Weeks Price Volatility (%):
61.78%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kindred Biosciences Inc is a US-based development-stage biopharmaceutical company which focuses on developing medicines for pets. Its lead products candidates are the intravenous (IV) form of Zimeta which is a dipyrone injection for the control of pyrexia in horses and Mirataz which is a mirtazapine transdermal ointment for the management of weight loss in cats. The product pipeline of the company consists of small molecules and biologics for a range of indications in dogs, cats, and horses, with focus near-term on equine small molecule products and canine and feline biologics products.

  Be the first to like this.
 


 

3352  2045  506  3059 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 VXRT 0.90+0.258 
 NIO 4.165+0.155 
 BBT 54.24+0.75 
 PFE 38.745-1.415 
Partners & Brokers